Tag Archives: NASDAQ:SELB

Selecta Biosciences (SELB) Gets a Buy Rating from William Blair

William Blair analyst Raju Prasad maintained a Buy rating on Selecta Biosciences (SELB – Research Report) today. The company’s shares closed last Thursday at $3.00. According to TipRanks.com, Prasad is a 5-star analyst with an average return of 14.4% and

Needham Keeps Their Buy Rating on Selecta Biosciences (SELB)

Needham analyst Chad Messer maintained a Buy rating on Selecta Biosciences (SELB – Research Report) today and set a price target of $5.00. The company’s shares closed last Thursday at $3.02. According to TipRanks.com, Messer is a 5-star analyst with

Analysts Offer Insights on Healthcare Companies: Selecta Biosciences (NASDAQ: SELB) and X4 Pharmaceuticals (NASDAQ: XFOR)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Selecta Biosciences (SELB – Research Report) and X4 Pharmaceuticals (XFOR – Research Report) with bullish sentiments. Selecta Biosciences (SELB) Canaccord Genuity analyst

Analysts Offer Insights on Healthcare Companies: Selecta Biosciences (NASDAQ: SELB), ImmunoGen (NASDAQ: IMGN) and Crispr Therapeutics AG (NASDAQ: CRSP)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Selecta Biosciences (SELB – Research Report), ImmunoGen (IMGN – Research Report) and Crispr Therapeutics AG (CRSP – Research Report) with bullish sentiments.

Selecta Biosciences (SELB) Received its Third Buy in a Row

After William Blair and Cantor Fitzgerald gave Selecta Biosciences (NASDAQ: SELB) a Buy rating last month, the company received another Buy, this time from Canaccord Genuity. Analyst John Newman maintained a Buy rating on Selecta Biosciences yesterday and set a

Selecta Biosciences (SELB) Initiated with a Buy at William Blair

Selecta Biosciences (SELB – Research Report) received a Buy rating from William Blair analyst Raju Prasad today. The company’s shares closed last Monday at $3.32, close to its 52-week high of $3.50. According to TipRanks.com, Prasad is a 5-star analyst